Neurostimulation improves movement in adults with spinal muscle atrophy

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.

Sanofi introduces new 340B payment model — report

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 23, 2024

Blue Shield of California Has Fix for MA Enrollees Worried About Co-Pays

With little fanfare, Blue Shield of California is again offering its “underwriting holiday” for two of its “Plan G” Medicare supplemental plans, with enrollment starting

September 29, 2023

Cannabis Markets Show Improved Growth Again

New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s monthly cannabis sales data for 11 states. Cannabis sales increased 1.0% sequentially in December after

February 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.